UNI-EN 9:Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 9 | / | 2021 | |||||||
| Date of issue: | 2021-03-26 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC) | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD invites all shareholders of the Company to exercise their voting right on the announced agenda items of the Extraordinary General Meeting convened for 2 April 2021 from 11:00 a.m. (8:00 a.m.) through correspondence. In an effort to preserve the normal operation of all the bodies of “Sopharma” AD and at the same time not to jeopardize the health of the interested parties in the conditions of a pandemic, the Board of Directors provide an opportunity for shareholders to exercise their voting rights in advance. The rules for voting by correspondence are described in detail in the invitation to convene the General Meeting. A sample declaration for voting by correspondence is attached to it. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_2021_EGM_notification_espi.pdf SFA_2021_EGM_notification_espi.pdf | Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC) | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2021-03-26 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 8.9 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
